| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.08 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.46 | 0.008 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |